In today’s rapidly evolving pharmaceutical landscape, regulatory authorities around the world place increasing emphasis on drug safety. As a result, Qualified Person for Pharmacovigilance (QPPV) services have become a critical component of global pharmacovigilance systems. QPPVs are responsible for the establishment and maintenance of the pharmacovigilance system, ensuring compliance with local and international regulations.
This blog explores the key role of QPPVs and how organizations can benefit from professional QPPV services across various global regions.
What is a QPPV?
A QPPV is a qualified professional appointed by a Marketing Authorization Holder (MAH) to ensure that their pharmacovigilance (PV) system meets regulatory requirements. The QPPV:
- Maintains oversight of the safety profile of all products
- Ensures timely submission of safety reports (ICSRs, PSURs/PBRERs, RMPs)
- Oversees the Pharmacovigilance System Master File (PSMF)
- Acts as the main contact for regulatory authorities on safety matters
Regional Overview of QPPV Services
🇪🇺 European Union
The EU mandates the appointment of a European QPPV for all centrally and nationally authorized products. This person must reside and operate within the EU and be available 24/7.
Key Responsibilities:
- Oversight of EU PV system
- Maintenance of the EU PSMF
- Liaising with EMA and national agencies
- Responding to safety queries and inspections
Support Services:
- EU QPPV outsourcing
- Local QPPVs in member states (e.g., France, Germany, Italy) for national registrations
- EU PSMF development and maintenance
🇬🇧 United Kingdom
Post-Brexit, the UK requires a UK QPPV for products authorized in Great Britain.
Requirements:
- UK-resident QPPV or EU QPPV with a UK National Contact Person
- Oversight of UK-specific pharmacovigilance activities
- Maintenance of a UK-specific annex to the PSMF
Support Services:
- UK QPPV/National Contact Person provision
- MHRA inspection readiness
- UK-specific PV system implementation
🇺🇸 United States
Although the FDA does not mandate a QPPV by name, similar responsibilities fall under the Designated Pharmacovigilance Officer or Responsible Person.
Core Responsibilities:
- Compliance with 21 CFR Part 314 & 600 (safety reporting)
- Oversight of PV activities including IND safety reports and periodic submissions
- FDA inspections and audit responses
Support Services:
- Local safety officer designation
- US-based PV contact and support
- Safety narrative reviews and signal detection oversight
Middle East & North Africa (MENA)
Countries like Saudi Arabia, UAE, Egypt, and Jordan have strengthened their PV frameworks. Many require a Local QPPV or Local Safety Officer (LSO).
Key Requirements:
- Residency of QPPV within the country
- Arabic-language submissions (where applicable)
- Direct reporting to local health authorities
Support Services:
- Local QPPVs/LSOs for GCC, Egypt, and Levant regions
- Regional PSMF and safety SOPs
- Compliance audits and gap assessments
Asia-Pacific (APAC)
China, Japan, India, and other APAC countries increasingly require local safety oversight, often mirroring EU QPPV requirements.
Japan
- Requires a local GVP Responsible Person (RMP)
- Must be fluent in Japanese and familiar with PMDA regulations
China
- Requires a Drug Safety Responsible Person under GVP guidelines
- Chinese-language documentation mandatory
India
- Mandates a local PV officer for licensed products
- CDSCO and PvPI submission compliance required
Support Services:
- Country-specific QPPV/LSO support
- Language-compliant documentation
- Local regulatory authority communication and safety case handling
Africa
Pharmacovigilance requirements are growing in South Africa, Nigeria, Kenya, and other African countries.
Regulatory Highlights:
- South Africa’s SAHPRA requires local PV systems
- Nigeria’s NAFDAC mandates submission of ICSR and periodic reports
Support Services:
- Local QPPV or PV contact person
- Training and system implementation
- Risk Management Plans and PV SOP setup
Why Partner with a Global QPPV Services Provider?
Outsourcing QPPV functions to a specialized service provider offers many advantages:
- Access to experienced and trained QPPVs across multiple jurisdictions
- Seamless global compliance management
- Scalable pharmacovigilance solutions for small to large pharma and biotech firms
- Inspection readiness and regulatory audit support
- Central and local PSMF management
Conclusion
As pharmacovigilance regulations evolve globally, the need for experienced, locally compliant QPPVs is more critical than ever. Whether operating in the EU, UK, US, MENA, APAC, or Africa, partnering with a reliable QPPV services provider ensures regulatory compliance, patient safety, and uninterrupted product availability.
Ready to ensure global PV compliance? Contact us today to explore our end-to-end QPPV solutions tailored to your market needs. mail us Bd@Vigilarebp.com to know more